𝔖 Bobbio Scriptorium
✦   LIBER   ✦

One-stop measurement of iron deposition in the anterior pituitary, liver, and heart in thalassemia patients

✍ Scribed by Wynnie W.M. Lam; W.Y. Au; Winnie C.W. Chu; S. Tam; S.Y. Ha; D.J. Pennell


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
145 KB
Volume
28
Category
Article
ISSN
1053-1807

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Purpose

To assess the feasibility of one‐stop evaluation of iron load of myocardium, liver, and anterior pituitary gland in thalassemia patients.

Materials and Methods

Fifty thalassemia major patients underwent a breath‐hold magnetic resonance imaging (MRI) sequence for assessment of T2* for liver and myocardium, a short axis cine trueFISP sequence covering base to apex to assess the ejection fraction of left ventricle, and a turbo spin echo T2‐weighted sequence for the anterior pituitary gland. The MRI parameters were correlated with serum growth hormone, insulin growth factor‐1 (IGF‐1), insulin growth factor binding protein‐3 (IGFBP‐3), and endocrine failure.

Results

Ferritin was found to be associated with T2* liver (P < 0.005), T2SI (signal intensity) pituitary (P = 0.001), and T2 pituitary/fat (P = 0.001), but not with T2* heart. There was significant correlation of T2SI pituitary with IGF‐1 and IGFBP‐3. T2* liver (P < 0.001), T2* heart (P < 0.001), pituitary SI (P < 0.001) and pituitary/fat SI (P = 0.002) were also found to be significantly correlated with a history of hypogonadism. T2* heart was also found to be significantly correlated with IGF‐1.

Conclusion

A quick MRI protocol for assessment of T2* liver, T2* heart, and T2SI pituitary is technically feasible. This might form an objective basis to monitor the response to different organs to chelation therapy. J. Magn. Reson. Imaging 2008. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


On improvement in ejection fraction with
✍ DJ Pennell; JP Carpenter; M Roughton; ZI Cabantchik 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 234 KB

## Background Trials of iron chelator regimens have increased the treatment options for cardiac siderosis in beta-thalassemia major (TM) patients. Treatment effects with improved left ventricular (LV) ejection fraction (EF) have been observed in patients without overt heart failure, but it is uncle

Is determination of the hepatic iron ind
✍ Miguel Yebra; Felix Lacoma; María Paz Queipo de Llano; María E. Moreno 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 1 views

Recently, Summers, Halliday and Powell (1) studied 42 patients with unequivocal primary hemochromatosis and six patients with equivocal initial results who after prolonged follow-up behaved as homozygotes. The researchers compared these patients with 15 heterozygous cases. In all subjects in the fir

Hepatic fat quantification using chemica
✍ Seung Soo Lee; Youngjoo Lee; Namkug Kim; Seong Who Kim; Jae Ho Byun; Seong Ho Pa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

## Abstract ## Purpose: To compare the accuracy of four chemical shift magnetic resonance imaging (MRI) (CS‐MRI) analysis methods and MR spectroscopy (MRS) with and without T2‐correction in fat quantification in the presence of excess iron. ## Materials and Methods: CS‐MRI with six opposed‐ and

Effects of iron salts and haemosiderin f
✍ D. Anderson; A. Yardley-Jones; R.J. Hambly; C. Vives-Bauza; V. Smykatz-Kloss; W. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 2 views

Thalassaemia is a group of genetic diseases where haemoglobin synthesis is impaired. This chronic anaemia leads to increased dietary iron absorption, which develops into iron overload pathology. Treatment through regular transfusions increases oxygen capacity but also provides iron through the red c